当前位置:首页 - 行情中心 - 康华生物(300841) - 财务分析 - 现金流量表

康华生物

(300841)

  

流通市值:60.67亿  总市值:64.84亿
流通股本:1.22亿   总股本:1.30亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金907,611,602.76548,424,276.75233,324,058.561,280,378,702.88
  收到其他与经营活动有关的现金35,004,080.6626,562,196.7223,056,630.5416,842,191.35
  经营活动现金流入小计942,615,683.42574,986,473.47256,380,689.11,297,220,894.23
  购买商品、接受劳务支付的现金45,882,215.922,731,713.144,836,327.1333,407,620.45
  支付给职工以及为职工支付的现金118,408,802.8882,935,284.0352,353,563.73152,471,745.48
  支付的各项税费112,800,987.6769,798,717.4729,478,284.1471,753,965.46
  支付其他与经营活动有关的现金392,259,885.87238,023,105.09148,839,837.28659,877,277.8
  经营活动现金流出小计669,351,892.32413,488,819.73235,508,012.28917,510,609.19
  经营活动产生的现金流量净额273,263,791.1161,497,653.7420,872,676.82379,710,285.04
二、投资活动产生的现金流量:
  收回投资收到的现金1,544,665,187.591,181,593,025.57451,000,0001,018,315,350.17
  取得投资收益收到的现金5,704,384.764,850,440.531,172,423.219,749,660.65
  处置固定资产、无形资产和其他长期资产收回的现金净额---67,869.46
  投资活动现金流入小计1,550,369,572.351,186,443,466.1452,172,423.211,028,132,880.28
  购建固定资产、无形资产和其他长期资产支付的现金29,520,104.7713,158,391.788,568,041.2270,785,928.9
  投资支付的现金2,412,000,0001,906,000,000992,000,000810,000,000
  取得子公司及其他营业单位支付的现金17,033,530.74---
  支付其他与投资活动有关的现金-70,000,000--
  投资活动现金流出小计2,458,553,635.511,989,158,391.781,000,568,041.22880,785,928.9
  投资活动产生的现金流量净额-908,184,063.16-802,714,925.68-548,395,618.01147,346,951.38
三、筹资活动产生的现金流量:
  取得借款收到的现金---179,793,800
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---179,793,800
  偿还债务支付的现金139,793,800139,793,800109,793,800226,784,905.68
  分配股利、利润或偿付利息支付的现金65,489,523.7865,489,523.78393,940.04136,430,355.71
  支付其他与筹资活动有关的现金442,705.95---
  筹资活动现金流出小计205,726,029.73205,283,323.78110,187,740.04363,215,261.39
  筹资活动产生的现金流量净额-205,726,029.73-205,283,323.78-110,187,740.04-183,421,461.39
四、汇率变动对现金及现金等价物的影响-37,818.87-28,086.65-14,104.0943,743.3
五、现金及现金等价物净增加额-840,684,120.66-846,528,682.37-637,724,785.32343,679,518.33
  加:期初现金及现金等价物余额1,143,392,808.71,143,392,808.71,143,392,808.7799,713,290.37
  期末现金及现金等价物余额302,708,688.04296,864,126.33505,668,023.381,143,392,808.7
补充资料:
  净利润-141,149,300.39-219,897,935.04
  资产减值准备-15,191,425.97-8,089,709.48
  固定资产和投资性房地产折旧-35,437,708.05-72,760,457.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,437,708.05-72,760,457.82
  无形资产摊销-1,597,237.42-4,008,303.32
  长期待摊费用摊销-8,437,677.67-11,753,812.35
  处置固定资产、无形资产和其他长期资产的损失---8,912.45
  固定资产报废损失-142,570.19-121,629.93
  公允价值变动损失--4,558,765.9-3,572,949.83
  财务费用-370,511.22-3,637,284.9
  投资损失--2,515,393.46--5,433,347.58
  递延所得税--1,516,212.93--4,780,003.24
  其中:递延所得税资产减少--1,558,512.93--4,780,003.24
    递延所得税负债增加-42,300--
  存货的减少-7,730,668.59-27,985,503.4
  经营性应收项目的减少--82,757,877.97-64,310,437.57
  经营性应付项目的增加-42,788,804.5--37,732,386.58
  现金的期末余额-296,864,126.33-1,143,392,808.7
  减:现金的期初余额-1,143,392,808.7-799,713,290.37
  现金及现金等价物的净增加额--846,528,682.37-343,679,518.33
公告日期2026-10-212026-08-182026-04-212026-04-21
审计意见(境内)标准无保留意见
TOP↑